MediPharm Labs Corp. (TSE:LABS – Get Free Report)’s stock price reached a new 52-week low during mid-day trading on Monday . The stock traded as low as C$0.06 and last traded at C$0.07, with a volume of 20035 shares. The stock had previously closed at C$0.07.
MediPharm Labs Stock Performance
The firm has a market cap of C$27.35 million, a PE ratio of -2.17 and a beta of 0.31. The company has a current ratio of 3.21, a quick ratio of 3.10 and a debt-to-equity ratio of 1.45. The business has a fifty day moving average price of C$0.07 and a 200 day moving average price of C$0.07.
MediPharm Labs (TSE:LABS – Get Free Report) last posted its earnings results on Thursday, November 13th. The company reported C($0.01) earnings per share for the quarter. The business had revenue of C$11.45 million for the quarter. MediPharm Labs had a negative return on equity of 24.41% and a negative net margin of 30.56%. Analysts forecast that MediPharm Labs Corp. will post -0.04 EPS for the current year.
MediPharm Labs Company Profile
MediPharm Labs Corp, along with its subsidiaries, produces purified, pharmaceutical-like cannabis extracts and related derivative products. The company generates revenue from Private label, White label, the Tolling process, and others. Some of its vape brands are Northern Lights, Blue Dream Pink Kush and GG4.
Featured Articles
- Five stocks we like better than MediPharm Labs
- About the Markup Calculator
- 3 Stocks Poised to Benefit From Google’s AI Breakthough
- 3 Warren Buffett Stocks to Buy Now
- Beyond NVIDIA: 5 Semiconductor Stocks Set to Dominate 2026
- 3 Grocery Stocks That Are Proving They Are Still Essential
- 3 Stocks You’ll Wish You Bought Before 2026
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
